Notably, 13-cis-retinoic acid, a drug commonly used for high-risk NB, can reduce apoptosis mediated by several chemotherapeutics through upregulating Bcl-2 and Bcl-XL, when applied in combination with those agents in several NB cell lines [169]. The gene discussed is BCL2; the disease is neuroblastoma.